The introduction of nicotinamide like a nicotine substitute in e-cigarette and smokeless merchandise represents a big regulatory problem with the FDA. Nicotinamide does not have nicotinic receptor agonist action and is thought to work as a sedative at superior dosages6. The claims produced by Nicotine River, ECBlend, along with other distributors t